In The News

Axcan to Acquire Eurand in Global Pharma Deal

Practices: Mergers & Acquisitions, Life Sciences, Life Sciences Mergers & Acquisitions, Securities & Public Companies

Ropes & Gray, led by partner Will Shields, is representing Axcan Holdings, Inc. in its proposed $583 million acquisition of Eurand, announced on Dec. 1. Axcan is a leading pharmaceutical company focused on the treatment of gastrointestinal disorders, and Eurand is a Dutch pharmaceutical company.
Cookie Settings